This news is covered by the Medical Dialogues Bureau present at the TCT Conference 2025, being held in San Francisco, USA.

Among U.S. adults aged 65 to 85 years, 8.2% have moderate or greater valvular heart disease (VHD), and when including those with mild-to-moderate disease, nearly one in five are affected, translating to more than 10 million older Americans living with clinically significant valve disease. These findings from the PREVUE-VALVE study were presented by Dr David J. Cohen of the Cardiovascular Research Foundation, New York, at TCT 2025.

The PREVUE-VALVE (Prevalence of Valvular Heart Disease in Older Americans) study is the first large-scale, population-representative investigation to define the true prevalence of valvular heart disease and its subtypes across the U.S. elde

See Full Page